Abagovomab, CAS 792921-10-9

Product Description: Abagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal anti-idiotypic antibody, against the tumor-associated antigen, CA-125. Abagovomab is generated by a mouse hybridoma, can imitate the human TAA, CA-125. Abagovomab can elicit humoral and cellular immune responses against ovarian cancer (oc)[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Pfisterer J, et al. The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR. Ann Oncol. 2006 Oct;17(10):1568-77./[2]Grisham RN, et al. Abagovomab: an anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer. Immunotherapy. 2011 Feb;3(2):153-62.

CAS Number: 792921-10-9

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99276-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99276-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK